Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension
Physicians' decision was the most common reason for not doing VRT in IPAH patients. Intermediate high-risk criteria presence at a baseline were associated with not done VRT due to physicians decision, negative VRT, and the vasoreactivity loss during the follow-up. CPET should be used more widely to detect the early signs of PAH progression in low risk or VRT + patients.
Authors
- А. В. Рыжков (ORCID: https://orcid.org/0000-0001-5226-1104)
- А. В. Березина (ORCID: https://orcid.org/0000-0002-5770-3845)
- E. M. Andreeva (ORCID: https://orcid.org/0000-0001-6081-1559)
- Irina Zlobina (ORCID: https://orcid.org/0000-0003-1161-4430)
- Garcia Perez Rosa Natalia
- О. М. Моисеева (ORCID: https://orcid.org/0000-0002-7817-3847)
- Kirill Lapshin
- Zhaneta Matakaeva
Institutions
- Federal Almazov North-West Medical Research Centre (RU)
Publication Details
- Journal
- Annals of Thoracic Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4103/atm.atm_189_24
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Russian Science Foundation